Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2235
Source ID: NCT00698230
Associated Drug: Incb013739
Title: Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: INCB013739|DRUG: INCB013739|DRUG: INCB013739|DRUG: INCB013739|DRUG: INCB013739|DRUG: Placebo comparator matching INCB013739|DRUG: Metformin
Outcome Measures: Primary: Change from Baseline to Week 12 in hemoglobin A1c (HbA1c), Baseline and Week 12 (or early termination study visit) | Secondary: Change from Baseline to Week 12 in fasting plasma glucose (FPG)., Baseline and Week 12 (or early termination study visit)
Sponsor/Collaborators: Sponsor: Incyte Corporation
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 302
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2008-05
Completion Date: 2009-05
Results First Posted:
Last Update Posted: 2018-02-14
Locations: Birmingham, Alabama, 35242, United States|Artesia, California, United States|Calabasas, California, 91307, United States|Fresno, California, 93720, United States|Los Angeles, California, 90057, United States|Los Gatos, California, 95032, United States|Santa Ana, California, United States|Colorado Springs, Colorado, 80909, United States|Chiefland, Florida, 32626, United States|Hollywood, Florida, 33021, United States|Longwood, Florida, 32779, United States|Miami Beach, Florida, 33140, United States|Miami, Florida, 33126, United States|Ocala, Florida, 34471, United States|Orlando, Florida, 32806, United States|South Miami, Florida, 33143, United States|Tampa, Florida, 33614, United States|Dunwoody, Georgia, 30338, United States|Rome, Georgia, 30165, United States|Belleville, Illinois, 62220, United States|Shawnee Mission, Kansas, 66216, United States|Bangor, Maine, 04401, United States|Columbia, Maryland, 21045, United States|Sterling Heights, Michigan, 48314, United States|Florissant, Missouri, 63031, United States|Saint Louis, Missouri, 63128, United States|Saint Louis, Missouri, 63141, United States|Las Vegas, Nevada, 89101, United States|New York, New York, 10016, United States|Springfield Gardens, New York, 11413, United States|West Seneca, New York, 14224, United States|Calabash, North Carolina, 95032, United States|Mooresville, North Carolina, 28117, United States|New Bern, North Carolina, 28562, United States|Winston-Salem, North Carolina, 27103, United States|Kettering, Ohio, 45429, United States|Norton, Ohio, 44614, United States|Norman, Oklahoma, 73071, United States|Altoona, Pennsylvania, 16601, United States|Harleysville, Pennsylvania, 19438, United States|Jenkintown, Pennsylvania, 19046, United States|Sellersville, Pennsylvania, 18960, United States|Greenville, South Carolina, 29615, United States|North Myrtle Beach, South Carolina, 29582, United States|Spartanburg, South Carolina, 29303, United States|Bristol, Tennessee, 37620, United States|Austin, Texas, 78705, United States|Dallas, Texas, 75230, United States|Georgetown, Texas, United States|Houston, Texas, 77004, United States|Houston, Texas, 77023, United States|Houston, Texas, 77074, United States|Houston, Texas, 77081, United States|Houston, Texas, 77090, United States|Midland, Texas, 79705, United States|North Richland Hills, Texas, 76180, United States|San Antonio, Texas, 78229, United States|Temple, Texas, 76502, United States|Waco, Texas, 76710, United States|Burke, Virginia, 22015, United States|Hampton, Virginia, 23666, United States|Milwaukee, Wisconsin, 53209, United States|Carolina, 00983, Puerto Rico|Fajardo, 00738, Puerto Rico|Ponce, 00716, Puerto Rico|Rio Grande, 00745, Puerto Rico|San Juan, 00909-1711, Puerto Rico|San Juan, 00926-2832, Puerto Rico
URL: https://clinicaltrials.gov/show/NCT00698230